As Shakespeare once posited: “To drain or not to drain. That is this the question.”
Perhaps it wasn’t him.
Surgeon preference typically dictates whether a drain makes sense. Keeping a hematoma from forming means avoiding one additional nidus of infection. But, a drain (even a closed drain), can also serve as a nidus of infection. I know the pros and cons do not end there. But, I want to change direction.
I received a call from a plastic surgeon in the Northeast. He placed implants in a patient. He also placed a Jackson Pratt drain. He left town for a long weekend. His nurse, who had removed many Jackson Pratt drains, tried to remove this drain. Seemed a little stuck, but, with a little added pressure, only some of the drain came out. The rest never slid out. It was left embedded in the wound, adjacent to the implant. It’s unclear whether a stray suture caught the drain. Or whether the drain was kinked and fractured at a weak point. Or some other hypothesis. But what was clear was that a piece of silastic remained in the patient.
Many surgeons will say that the rest of the drain needs to come out.
But, going back in means opening the wound, and exposing the implant to potential infection.
There’s risk of infection with going back in. There’s risk of infection with leaving the wound alone.
Part of the calculus becomes a matter of optics. Patients expect that we will not leave needles, drains, or surgical tools inside of them. But, we don’t chase all bullets in trauma patients just to get a clean X-ray.
A real risk-benefit analysis must look at the added risk of fishing out the fragment.
No doctor wants to be that defendant explaining why a drain fragment was left in. But, if a patient experiences an added complication just because of the optics, have their interests been served.
There’s no perfect answer to this dilemma.
What do you think? Tell us below.
Take Advantage of Our Review Monitoring Service
We provide qualified applicants with free review monitoring for 6 week. Reports delivered bi-weekly.
Request a Consultation with Our Founder
Medical Justice Founder and CEO, Jeff Segal, MD, JD, provides consultations to doctors in need of guidance.
Meet the Experts Driving Medical Justice
Our Executive Team walks with our member doctors until their medico-legal obstacles are resolved - we've seen it all.
Jeffrey Segal, MD, JD
Chief Executive Officer and Founder
Dr. Jeffrey Segal, Chief Executive Officer and Founder of Medical Justice, is a board-certified neurosurgeon. Dr. Segal is a Fellow of the American College of Surgeons; the American College of Legal Medicine; and the American Association of Neurological Surgeons. He is also a member of the North American Spine Society. In the process of conceiving, funding, developing, and growing Medical Justice, Dr. Segal has established himself as one of the country’s leading authorities on medical malpractice issues, counterclaims, and internet-based assaults on reputation.
Dr. Segal was a practicing neurosurgeon for approximately ten years, during which time he also played an active role as a participant on various state-sanctioned medical review panels designed to decrease the incidence of meritless medical malpractice cases.
Dr. Segal holds a M.D. from Baylor College of Medicine, where he also completed a neurosurgical residency. Dr. Segal served as a Spinal Surgery Fellow at The University of South Florida Medical School. He is a member of Phi Beta Kappa as well as the AOA Medical Honor Society. Dr. Segal received his B.A. from the University of Texas and graduated with a J.D. from Concord Law School with highest honors.
In 2000, he co-founded and served as CEO of DarPharma, Inc, a biotechnology company in Chapel Hill, NC, focused on the discovery and development of first-of-class pharmaceuticals for neuropsychiatric disorders.
Dr. Segal is also a partner at Byrd Adatto, a national business and health care law firm. With over 50 combined years of experience in serving doctors, dentists, and other providers, Byrd Adatto has a national pedigree to address most legal issues that arise in the business and practice of medicine.